相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1
Mao Lin et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells o severe congenital neutropenia patients
Masoud Nasri et al.
HAEMATOLOGICA (2020)
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
Giulia Schiroli et al.
CELL STEM CELL (2019)
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Kendell Clement et al.
NATURE BIOTECHNOLOGY (2019)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
Two paternal mosaicism of mutation in ELANE causing severe congenital neutropenia exhibit normal neutrophil morphology and ROS production
Qiao Liu et al.
CLINICAL IMMUNOLOGY (2019)
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Falak Sher et al.
NATURE GENETICS (2019)
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Rik G. H. Lindeboom et al.
NATURE GENETICS (2019)
Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation
Hannah Gelman et al.
GENOME MEDICINE (2019)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells
Pamela Y. Ting et al.
NATURE METHODS (2018)
A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis
Rikin K. Shah et al.
PEDIATRIC BLOOD & CANCER (2017)
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
David W. Morgens et al.
NATURE COMMUNICATIONS (2017)
Severe congenital neutropenias
Julia Skokowa et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Understanding chronic neutropenia: life is short
Marije Bartels et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Neutral serine proteases of neutrophils
Ralph Kettritz
IMMUNOLOGICAL REVIEWS (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
The rules and impact of nonsense-mediated mRNA decay in human cancers
Rik G. H. Lindeboom et al.
NATURE GENETICS (2016)
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
Arnold Park et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Mosaicism of an ELANE Mutation in an Asymptomatic Mother in a Familial Case of Cyclic Neutropenia
Osamu Hirata et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells
Ramesh C. Nayak et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Paternal Somatic Mosaicism of a Novel Frameshift Mutation in ELANE Causing Severe Congenital Neutropenia
Hee-Jung Kim et al.
PEDIATRIC BLOOD & CANCER (2015)
Nonirradiated NOD,B6.SCID Il2rγ-/- KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
Brian E. McIntosh et al.
STEM CELL REPORTS (2015)
Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms
Timothy Tidwell et al.
BLOOD (2014)
Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses
Ole E. Sorensen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation
John G. Doench et al.
NATURE BIOTECHNOLOGY (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
ELANE Mutations in Cyclic and Severe Congenital Neutropenia Genetics and Pathophysiology
Marshall S. Horwitz et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
The Spectrum of ELANE Mutations and their Implications in Severe Congenital and Cyclic Neutropenia
Manuela Germeshausen et al.
HUMAN MUTATION (2013)
A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45
Thierry Vilboux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Variability of bone marrow morphology in G6PC3 mutations: Is there a genotype-phenotype correlation or age-dependent relationship?
Siddharth Banka et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane
Suparna Nanua et al.
BLOOD (2011)
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
Hiroshi Ban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Comparison of human cord blood engraftment between immunocompromised mouse strains
Sean P. McDermott et al.
BLOOD (2010)
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy
Philip S. Rosenberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Cyclic Neutropenia and Severe Congenital Neutropenia in Patients With a Shared ELANE Mutation and Paternal Haplotype: Evidence for Phenotype Determination by Modifying Genes
Peter E. Newburger et al.
PEDIATRIC BLOOD & CANCER (2010)
Resolving a genetic paradox throughout preimplantation genetic diagnosis for autosomal dominant severe congenital neutropenia
Mira Malcov et al.
PRENATAL DIAGNOSIS (2010)
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
Kaan Boztug et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis
David S. Grenda et al.
BLOOD (2007)
Neutrophil elastase in cyclic and severe congenital neutropenia
Marshall S. Horwitz et al.
BLOOD (2007)
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response
Inga Koellner et al.
BLOOD (2006)
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
Philip S. Rosenberg et al.
BLOOD (2006)
Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin
XG Hou et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2005)
Papillon-Lefevre syndrome: Correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans
CTN Pham et al.
JOURNAL OF IMMUNOLOGY (2004)
Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells
CH Jin et al.
GENE THERAPY (2003)
Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis
DS Grenda et al.
BLOOD (2002)
Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia
PJ Ancliff et al.
BLOOD (2002)